Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
KOREA E & EX

Circulatory Support System Aids Failing Hearts

By HospiMedica International staff writers
Posted on 09 Jul 2013
Print article
Image: The Synergy Circulatory Support System (Photo courtesy of CircuLite).
Image: The Synergy Circulatory Support System (Photo courtesy of CircuLite).
A surgically implanted micropump aids ambulatory chronic heart failure (CHCF) patients who not respond to optimal medical treatment.

The Synergy Circulatory Support System is designed to reverse HF symptoms in ambulatory patients, promoting significant hemodynamic improvements, including decreased pulmonary artery and pulmonary capillary wedge pressures and increased cardiac output. The device provides up to 4.25 liters of blood per minute, reducing the heart's workload while improving blood flow to the final organs. The system is surgically implanted using a mini-thoracotomy procedure and the micro-pump is placed in a pacemaker-like pocket. The procedure is intended to reduce the surgical risks associated with cardiopulmonary bypass support platforms needed to place current ventricular assist devices (VADs).

The micropump combines axial, centrifugal, and orthogonal flow paths with a single-stage impeller that is powered by an integrated brushless microelectric motor; the entire system is the size of a standard AA battery. The design allows the motor to be sealed, thus eliminating blood contact in the motor, as well as a proprietary self-washing flow path and an alternating speed algorithm, both designed to minimize the risk of thrombus formation in or around the rotor. The Synergy Circulatory Support System is a product of CircuLite (Aachen, Germany) and has received the European Community CE marking of approval.

“The latest version of the Synergy System was shown to improve hemodynamics and functional status with comparably low adverse event rates in chronic ambulatory heart failure patients,” said Professor Bart Meyns, MD, PhD, chief of cardiac surgery at the University Hospitals Leuven (Belgium), who conducted the study in the final 26 patients of the clinical Synergy CE-Mark Trial. “The System has the potential for broad application in earlier-stage patients, who are not sick enough to justify the risks associated with more surgically-invasive assist devices.”

“The final modifications we made to the Synergy System have made a significant clinical difference, which was demonstrated in our clinical trial,” said Paul Southworth, CEO of CircuLite. “We showed positive outcomes and we have lowered adverse events in comparison to larger devices.”

Related Links:
CircuLite



Print article
LevMed LTD.

Channels

Surgical Techniques

view channel

Coronary Clot Aspiration Provides No MI Survival Benefit

Thrombectomy did not improve outcomes for myocardial infarct (MI) patients presenting after symptom onset, according to a new study. Researchers at University College London (UCL; United Kingdom), the University of Manchester (United Kingdom), and other institutions conducted a retrospective study based on a UK national... Read more

Women's Health

view channel
Image: The Eclipse vaginal insert in deflated (L) and Inflated (R) states (Phoyo courtesy of Pelvalon).

Vaginal Insert Offers Alternative Treatment for Fecal Incontinence

A novel vaginal insert for bowel control eliminates the need for surgery or an in-office procedure for the treatment of female fecal incontinence (FI). The second-generation Eclipse System is comprised... Read more

Health IT

view channel
Image: The Rigel 62353 Plus tester (Photo courtesy of Rigel Medical).

Advanced Safety Tester Analyzes Diverse Medical Devices

An upgraded dedicated tester meets international standards for in-service and post-repair safety testing of 24 V and 48 V DC medical electronic devices. The Rigel 62353 Plus tester offers a range of... Read more

Hospital News

view channel
Image: Site of the new HSS outpatient center in Westchester County (Photo courtesy of the RPW Group).

Hospital for Special Surgery Opens New Outpatient Center

The Hospital for Special Surgery (HSS; New York, NY, USA) has leased a 4,645 m² space in White Plains (NY, USA) from RPW Group (Rye Brook, NY, USA), which will serve as the new HSS outpatient center in... Read more

Business

view channel

Global Call for Action Against Drug-Resistant Infections

More than 80 leading international bodies came together to call on governments and industry to work in parallel and take comprehensive action against drug-resistant infections, as proclaimed in a joint declaration released at the World Economic Forum (Cologny, Switzerland), held during January 2016 in Davos (Switzerland).... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.